Article
Increased susceptibility to ischemia-induced brain damage in transgenic mice overexpressing a dominant negative form of SHP2.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology - 1 Oct 2000
Aoki Y, Huang Z, Thomas S S, Bhide P G, Huang I, Moskowitz M A, Reeves S A
Abstract excerpt
Cell culture studies have established SH2 domain-containing protein tyrosine phosphatase-2 (SHP2) as an important factor in growth factor and cytokine-activated signaling pathways. However, the significance of SHP2 in the mammalian central nervous system (CNS) is not known since early embryonic lethality occurs in shp2 null mice. To bypass this embryonic lethality, transgenic animals containing a catalytically...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
